Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 9:25 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 889–912 of 5,911 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: mRI Clear all

Conditions: Obsessive Compulsive Disorder
Interventions: Behavior Therapy; Behavioral
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 60 Years
Enrollment: 54 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2019
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acute Myeloid Leukemia, Acute Promyelocytic Leukemia With PML-RARA
Interventions: Computed Tomography, Diffusion Weighted Imaging, Fludeoxyglucose F-18, Gadolinium, Magnetic Resonance Imaging, Positron Emission Tomography, Three-Dimensional Spoiled Gradient MRI; Procedure · Radiation · Drug
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2027
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Intraventricular Hemorrhage of Prematurity
Interventions: Thyroxine, Placebo; Drug
Lead sponsor: Albert Einstein College of Medicine; Other
Eligibility: 3 Days to 6 Days
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: Focal Brain Lesion, Focal Lesions, fMRI
Interventions: Not listed
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 100 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: Started 2012
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Cardiovascular Disease, Healthy
Interventions: Not listed
Lead sponsor: National Heart, Lung, and Blood Institute (NHLBI); NIH
Eligibility: 18 Years to 80 Years
Enrollment: 497 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 1996 – 2011
U.S. locations: 1
States / cities: Bethesda, Maryland

Conditions: Prostate Cancer
Interventions: multi-parametric MRI(MP-MRI), dynamic contrast-enhanced MRI (DCE), biopsy; Device · Procedure
Lead sponsor: Memorial Sloan Kettering Cancer Center; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2026
U.S. locations: 8
States / cities: Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 5 more

Conditions: LAMA2-MD (Merosin Deficient Congenital Muscular Dystrophy, MDC1A)
Interventions: Not listed
Lead sponsor: Cure CMD; Other
Eligibility: Not listed
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2014
U.S. locations: 1
States / cities: San Pedro, California

Conditions: Hypertension, Mild Cognitive Impairment
Interventions: Mindfulness and DASH Diet Education, Education group; Behavioral
Lead sponsor: Ohio State University; Other
Eligibility: 65 Years and older
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2020
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Epilepsy, Status Epilepticus, Epilepsia Partialis Continua, Epilepsia Partialis Continua, Refractory (Medically)
Interventions: Low frequency repeated TMS (LF-rTMS); Device
Lead sponsor: Baptist Health South Florida; Other
Eligibility: 18 Years to 80 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Colorectal Cancer
Interventions: Ferumoxytol, Magnetic Resonance Imaging; Drug · Other
Lead sponsor: Scott Potenta, MD, PhD; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Burlington, Vermont

Conditions: Papillary Carcinoma of Thyroid Gland, Metastatic Medullary Thyroid Cancer, Follicular Thyroid Cancer Lymph Node Metastasis
Interventions: Ferumoxytol, Nanoparticle MRI; Drug · Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Healthy Participants
Interventions: Functional magnetic resonance imaging (fMRI); Other
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 55 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Conditions: Brain Cancer Metastatic, CMV Viremia
Interventions: Valganciclovir; Drug
Lead sponsor: The Methodist Hospital Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 28 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2030
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Endometrial Cancer
Interventions: Not listed
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older · Female only
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Aging
Interventions: Motivational MRI and Behavioral Intervention, Control MRI and Behavioral Intervention; Behavioral
Lead sponsor: Northeastern University; Other
Eligibility: 60 Years to 95 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Magnetic Resonance Imaging, Cerebrovascular Circulation
Interventions: MRI, Prazosin, Placebo; Device · Drug
Lead sponsor: University of Wisconsin, Madison; Other
Eligibility: 55 Years to 69 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Madison, Wisconsin

Conditions: Stroke, Dyslexia, Acquired
Interventions: Motor Imagery and Real-Time fMRI Neurofeedback, Motor Imagery and Sham fMRI Neurofeedback; Behavioral
Lead sponsor: Kessler Foundation; Other
Eligibility: 18 Years to 80 Years
Enrollment: 28 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: West Orange, New Jersey

Conditions: Osteoarthritis, Knee
Interventions: Magnetic Resonance Imaging; Other
Lead sponsor: American College of Radiology; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 5
States / cities: Hershey, Pennsylvania • Philadelphia, Pennsylvania • Pittsburgh, Pennsylvania

Conditions: Type 2 Diabetes, Oxidative Stress
Interventions: ascorbic acid (Vitamin C); Biological
Lead sponsor: In-Young Choi, Ph.D.; Other
Eligibility: 30 Years to 55 Years
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2014
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Brain Tumor Adult
Interventions: MR Perfusion Scan, 2HG Spectroscopy Scan, Standard of Care Intraoperative MRI; Device
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2025
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Glioma, Malignant Brain Neoplasm, Meningioma, Metastatic Malignant Neoplasm in the Brain
Interventions: Advanced Magnetic Resonance Imaging, Brain Surgery, Electronic Health Record Review, Immuno-Positron Emission Tomography Scan, Magnetic Resonance Imaging, Stereotactic Biopsy, Zirconium Zr 89 Crefmirlimab Berdoxam; Procedure · Other · Diagnostic Test
Lead sponsor: Jonsson Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2028
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Localized Resectable Neuroblastoma, Localized Unresectable Neuroblastoma, Regional Neuroblastoma, Stage 4 Neuroblastoma, Stage 4S Neuroblastoma
Interventions: Clinical Observation, Cyclophosphamide, Laboratory Biomarker Analysis, Magnetic Resonance Imaging, Prednisone, Therapeutic Immune Globulin; Other · Drug · Procedure + 1 more
Lead sponsor: Children's Oncology Group; Network
Eligibility: Up to 8 Years
Enrollment: 53 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2022
U.S. locations: 97
States / cities: Birmingham, Alabama • Tucson, Arizona • Little Rock, Arkansas + 78 more

Conditions: Heart Failure With Preserved Ejection Fraction, Healthy
Interventions: MRI (cardiac) off-label use gadolinium contrast (IND exempt), MRI (cardiac); Diagnostic Test
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2022
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Myeloma
Interventions: MRD Assessment; Other
Lead sponsor: Rajshekhar Chakraborty, MD; Other
Eligibility: 18 Years and older
Enrollment: 36 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: New York, New York

Search by objective public record fields.

Fear Extinction and Mechanisms of Change in Obsessive Compulsive Disorder

PET/MRI, 18F-FDG PET/CT and Whole Body MRI in Finding Extramedullary Myeloid Leukemia in Patients With Newly Diagnosed Acute Myeloid Leukemia

Thyroxine Treatment in Premature Infants With Intraventricular Hemorrhage

Top-Down Attentional Control of Visual-Processing

Magnetic Resonance Imaging at Different Levels of Magnetic Intensity

Evaluation of Treatment Response Using Multiparametric MRI After Prostate Radiotherapy

LAMA2-related Muscular Dystrophy Brain Study

Brain Connections and Blood Pressure

Repeated TMS at Low Frequencies to Reduce Seizure Occurrence

Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer

Pre-Operative Nodal Staging of Thyroid Cancer Using USPIO MRI: Preliminary Study

Targeting Large-scale Networks in Depression With Real-time fMRI (Functional Magnetic Resonance Imaging) Neurofeedback

Trial to Study Anti- HCMV Therapy in Breast Cancer Patients With Progressive Intracranial Metastases and CMV Infection

Efficacy of PET/MRI in Detecting Metastatic Disease in Endometrial Cancer

Daily Activity Study of Health: Increasing Physical Activity in Aging

Brain Blood Vessel Responses to Changes in Blood Flow

Neurofeedback Intervention for Reading Deficits in Subacute Stroke

MRI Markers of Cartilage Damage in Knee With Osteoarthritis

Quantitative in Vivo Biomarkers of Oxidative Stress in Diabetes

Safety and Feasibility of Preoperative and Intraoperative Image-Guided Resection of Gliomas

Zr-89 Crefmirlimab Berdoxam and Immuno-Positron Emission Tomography for the Imaging of Patients With Resectable Brain Tumors

Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma

Understanding the Mechanisms of Diastolic Dysfunction

Non-invasive MRD Assessment in Multiple Myeloma